The COVID-19 Pandemic – News and Features

Results from a small clinical trial show that the Parkinson’s disease drug ropinirole delayed the progression of amyotrophic lateral sclerosis (ALS) by an average of 27.9 weeks.

A brightly colored microcrystal that loses its color over time depending on temperature could be used to identify whether a vial of medicine has gotten too warm.

The Covid pandemic shutdowns in South Asia greatly reduced the concentration of short-lived cooling particles in the air, while the concentration of long-lived greenhouse gases was barely affected.

In this article, we highlight some of the key technologies fueling digital transformation and explore the impacts they are having on laboratory efficiencies.

In this article, we look at two of the hottest areas in protein engineering for therapeutic applications and how machine learning and artificial intelligence is set to transform the field.

Researchers have developed a scoring system based on patient-reported symptoms that can identify individuals with long COVID.

Researchers have identified a novel signaling molecule that could lead to the development of novel therapeutics for the prevention and treatment of obesity and diabetes.

NIH-funded research effort identifies most common symptoms, potential subgroups, and initial symptom-based scoring system – with aim of improving future diagnostics and treatment.

An research team have been developing a personalized mRNA cancer-treatment vaccine approach. It is designed to help immune cells recognize specific neoantigens on patients’ pancreatic cancer cells.

A new tool which could help reduce the spread of antimicrobial resistance is showing early promise, through exploiting a bacterial immune system as a gene editing tool.